61 – 70 of 109
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
The safety of introducing a new generation TAVR device : One departments experience from introducing a second generation repositionable TAVR
(
- Contribution to journal › Article
-
Mark
Intravascular Ultrasound Guidance is Associated with Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared with Angiography Guidance Alone
(
- Contribution to journal › Article
-
Mark
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
(
- Contribution to journal › Article
-
Mark
Diabetic patients with acute coronary syndromes in contemporary European registries : Characteristics and outcomes
(
- Contribution to journal › Article
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
- 2016
-
Mark
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.
(
- Contribution to journal › Article
-
Mark
Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction - A registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
(
- Contribution to journal › Article